What qualifications do you need for Mounjaro in the UK?

Step 1: Check whether the BMI and condition thresholds apply to you

The starting point for Mounjaro eligibility under its UK licence is your BMI. A BMI of 30 or above qualifies on its own. If your BMI sits between 27 and 29.9, you need at least one weight-related condition alongside it, common examples include high blood pressure, type 2 diabetes, pre-diabetes, dyslipidaemia (raised cholesterol or triglycerides), or obstructive sleep apnoea. Osteoarthritis related to excess weight is also recognised. The NHS tirzepatide medicines page sets out the licensed indications clearly if you want to read the clinical language yourself.

For some ethnic backgrounds (including South Asian, Chinese, Middle Eastern, Black African, and African-Caribbean backgrounds) UK guidance reduces the qualifying BMI thresholds by 2.5 kg/m². So a BMI of 27.5 with a weight-related condition may be sufficient where 30 would otherwise be the entry point. If you are unsure of your exact BMI, the NHS BMI calculator at nhs.uk gives a reliable figure in under a minute.

One thing worth knowing: meeting the BMI threshold is the floor, not the whole conversation. It opens the door to a prescriber assessment, it does not guarantee a prescription. The clinical review that follows is where the real qualification decision is made.

Step 2: Understand what the prescriber is looking for beyond the numbers

Once the BMI and condition boxes are ticked, a prescriber looks at the broader picture. This is the part of the process that online eligibility checklists cannot replace. Mounjaro is not suitable for everyone who meets the headline criteria, and a good prescriber will say so plainly.

Conditions that rule out Mounjaro entirely include a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia type 2, and a previous serious allergic reaction to tirzepatide or any component of the pen. A history of pancreatitis requires careful prescriber discussion before treatment begins. Certain gastrointestinal conditions that affect stomach emptying are also relevant. You can read about contraindications and complications in more detail to understand which conditions prompt a closer look.

Current medications matter too. Tirzepatide slows gastric emptying, which can alter how quickly other drugs are absorbed. Women taking oral contraceptives need a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because the pill's absorption may be reduced. If you are on multiple medicines, reviewing them before starting is essential, our page on Mounjaro and other medications covers the main interactions worth knowing about.

Pregnancy, breastfeeding, and actively trying to conceive are all situations where Mounjaro is not recommended. Under-18s are not within the licensed population either. These points come up at consultation, not as a surprise later.

Step 3: How the clinical assessment works at a regulated online pharmacy

At a regulated UK service, qualification for Mounjaro runs through a structured consultation, not a rubber stamp. At nume, that means photo-ID identity verification, live weight confirmation on video, and a prescriber (a real clinician, listed on the GPhC register) reading your answers the same day. Transfer patients and anyone seeking a dose increase provide supporting evidence as part of that review.

The prescriber's decision is exactly that: a clinical decision. If something in your history or medication list raises a concern, the prescriber will flag it and explain why. The consultation is free, and there is no obligation to proceed. For a fuller look at what tirzepatide is, how it works as a dual GIP and GLP-1 receptor agonist, and what the clinical trials showed, the tirzepatide overview has that detail.

One practical note: once approved, your Mounjaro pen is dispatched the same day (for orders placed before 12pm, Monday to Friday) and arrives the next working day in plain packaging. If you are wondering whether your GP needs to be notified when you get Mounjaro through a private pharmacy, that is a question worth answering before you order. Store it in the fridge as soon as it arrives, most people slot it in the fridge door alongside other weekly staples and that routine tends to stick.

NHS eligibility versus private prescription: they are not the same criteria

A common source of confusion is that the qualifications for Mounjaro on the NHS are significantly stricter than the private licensed criteria above. NICE's appraisal TA1026 recommends tirzepatide for NHS use only in adults with a BMI of 35 or above and at least one weight-related comorbidity, within a specialist weight management pathway. Cohort 2 of the NHS rollout (from June 2026) covers BMI 35 to 39.9 with four or more qualifying conditions. Future cohorts will widen access further, but that process is phased and slow.

If you do not meet the NHS criteria, or you would rather not wait, a private prescription via a GPhC-registered pharmacy is the legal alternative, provided you qualify under the licensed indications. That distinction matters: private prescription does not mean lower clinical standards. It means the same prescription-based process, without the NHS pathway's additional eligibility gates. For more on what the licensed indications cover, this page on Mounjaro indications goes through them in full. And if cost is a factor in your thinking, a transparent breakdown of what private treatment involves is on the Mounjaro prices page.